Matthew Winton - 14 Nov 2025 Form 4 Insider Report for CervoMed Inc. (CRVO)

Role: Chief Commercial and Business
Signature: /s/ William R. Elder, attorney-in-fact for the Reporting Person
Issuer symbol: CRVO
Transactions as of: 14 Nov 2025
Transactions value $: $75,700
Form type: 4
Filing time: 17 Nov 2025, 09:01:17 UTC
Previous filing: 08 Oct 2025
Next filing: 19 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Winton Matthew	Chief Commercial and Business	C/O CERVOMED INC., 20 PARK PLAZA, SUITE 424, BOSTON	/s/ William R. Elder, attorney-in-fact for the Reporting Person	17 Nov 2025	0001971400

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRVO	Common Stock	Purchase	$75.7K	+10K		$7.57	10K	14 Nov 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares purchased in open-market transactions.
F2	The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.53 to $7.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range.

Content

Shares purchased in open-market transactions.

The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.53 to $7.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range.